Association of progesterone receptor status with 21-gene recurrence score and survival among patients with estrogen receptor-positive breast cancer

Abstract Background Progesterone receptor (PR)-negative tumors have been shown to have worse prognosis and were underrepresented in recent trials on patients with estrogen receptor (ER)-positive breast cancer. The role of PR-negative status in the context of 21-gene recurrence score (RS) and nodal s...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Sung Jun Ma, Jasmin Gill, Keerti Yendamuri, Udit Chatterjee, Olivia Waldman, Cynthia Dunne-Jaffe, Fatemeh Fekrmandi, Rohil Shekher, Austin Iovoli, Song Yao, Oluwadamilola T. Oladeru, Anurag K. Singh
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	BMC 2023-04-01
Saila:	BMC Cancer
Gaiak:	PR status Oncotype score Chemo Chemotherapy
Sarrera elektronikoa:	https://doi.org/10.1186/s12885-023-10796-4
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!